Carlos R Figueiredo

10PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer cell biologyPhycology (incl. marine grasses)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 22, 2026
Spatial Transcriptomic and Proteomic Analysis Identifies Novel Immune-Associated Biomarkers of Anti-PD1 Response in Metastatic Melanoma.

|May 05, 2026
Novel CRISPR-Cas9 BAP1 knockout pre-clinical tumor model recapitulates human melanoma tumorigenesis and immune evolution.

|May 22, 2024
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity.

Miriam Langguth, Eleftheria Maranou, Saara A Koskela

|Sep 19, 2023
From antimicrobial to anticancer: the pioneering works of Prof. Luiz Rodolpho Travassos on bioactive peptides.

Saara A Koskela, Carlos R Figueiredo

|Jul 15, 2023
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities.

Mona Meng Wang, Sarah E Coupland, Tero Aittokallio

|Feb 24, 2023
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities.

Maisoon Matareed, Eleftheria Maranou, Saara A Koskela

Pageof 2

Frequent Collaborators

2 joint publications

Roosa E Kallionpää

2 joint publications

Maria Sundvall

2 joint publications

Sarah E Coupland

2 joint publications

Eleftheria Maranou